2024 CADTH Symposium - Call for Abstract Reviewers Question Title * 1. Prefix Ms. Mr. Mx. Dr. Prof. Other Question Title * 2. First Name (Required.) Question Title * 3. Last Name (Required.) Question Title * 4. Title (Required.) Question Title * 5. Organization / Academic Institution (Required.) Question Title * 6. Email (Required.) Question Title * 7. Address (Required.) City Province/Territory Country Question Title * 8. Background (please check all that apply) (Required.) Clinician or health care provider Drug review and/or HTA agency Federal/Provincial/Territorial Government Employee Graduate or undergraduate student Health Economist International publicly funded health sector Medical devices company representative or consultant Pan-Canadian health organization Patient group and/or patent group representative Pharmaceutical company representative or consultant Policy-Maker or Administrator Regional health authority and/or hospital Researcher Staff from health professional association University staff/academia Other (please specify) Question Title * 9. Are you a health care professional with clinical expertise? (Required.) Yes No If "Yes", please list area(s) of clinical expertise. Question Title * 10. Your Expertise (check all that apply) (Required.) Access to promising technologies Advancing transparency in HTA Clinician engagement Collaborative initiatives involving multiple stakeholders Digital health and artificial intelligence Disinvestment Drugs Drugs for rare diseases Enhanced collaboration between the regulatory and reimbursement environments Ethics Health economics Health services for underserved populations Horizon scanning and early HTA Hospital-based HTA HTA as an enabler of innovation HTA’s role in addressing climate change HTA methods Impact evaluation Implementation support to enhance adoption of HTA advice and recommendations Inclusion, Diversity, Equity, and Accessibility Indigenous Health Knowledge mobilization and knowledge transfer Maximizing the impact of HTA Medical devices Mental health and addictions services Oncology Optimizing the use of real-world evidence Patient, caregiver, and public engagement Policy Issues Other (please specify) Question Title * 11. Do you have experience in health technology assessment methodology? (Required.) Yes No If "Yes", please specify the area(s) of health technology assessment methodology. Question Title * 12. Language (check all that apply) (Required.) English French Done